Patient Immunotherapy Summit: Pancreatic Cancer Brief January 8, 2024January 8, 2024 Max Mallet Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading cause of cancer deaths in the U.S. Elizabeth M. Jaffee, MD, the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and CRI Scientific Advisory Council associate director, focuses her research on pancreatic cancer. Dr. Jaffee gives a detailed overview of pancreatic cancer and its treatment landscape. Read more: Post navigation Immunotherapy 101: What is Immunotherapy and How Does it Work? Read Story Patient Immunotherapy Summit: Ovarian Cancer Brief Read Story
